Document Detail


Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
MedLine Citation:
PMID:  15998429     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To determine whether serum hyaluronic acid reliably predicts the severity of hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). METHODS: We studied 79 patients with histologically confirmed NAFLD. Hyaluronic acid was measured in serum obtained at the time of liver biopsy. Severity of fibrosis was staged based on Brunt's classification. The prediction levels for fibrosis were determined by area under the receiver operating characteristic curve (AUC). RESULTS: The logarithm of serum hyaluronic acid was significantly different among the stages of fibrosis (P<0.0001, analysis of variance) and had a significant positive correlation with the degrees of fibrosis after adjusting for age and serum albumin (partial r=0.44, P<0.0001). AUCs were 0.67, 0.87, 0.89, and 0.92 for any levels of fibrosis, > or =moderate fibrosis, > or =severe fibrosis, and cirrhosis, all of which were significantly higher than 0.5 (P<0.05). The cut-off value of serum hyaluronic acid of 46.1 mug/l was associated with the highest AUC for severe fibrosis, yielding a sensitivity of 85% and a specificity of 80%. The corresponding positive and negative predictive values were 51% and 96%, when assuming prevalence of severe fibrosis in NAFLD patients of 20% at referral centers. CONCLUSIONS: Measurement of serum hyaluronic acid is useful to identify NAFLD patients with severe fibrosis.
Authors:
Ayako Suzuki; Paul Angulo; James Lymp; Dave Li; Shinji Satomura; Keith Lindor
Related Documents :
238799 - Determination of isonicotinic acid hydrazide in serum.
51859 - Effect of decalcifying agents on the staining of mycobacterium tuberculosis.
2306479 - Determination of the presence of ceramide aminoethylphosphonate and ceramide n-methylam...
3708819 - Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids.
22296509 - The combined effects of π-π stacking and hydrogen bonding on the (n1) acidity of urac...
22579329 - Determination of the floral origin of some romanian honeys on the basis of physical and...
12121809 - Dynamic determination and possible mechanism of amino acid transmitter release from rat...
14733499 - Gc-ms determination of flavonoids and phenolic and benzoic acids in human plasma after ...
2948509 - Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in usher...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver international : official journal of the International Association for the Study of the Liver     Volume:  25     ISSN:  1478-3223     ISO Abbreviation:  Liver Int.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-06     Completed Date:  2005-11-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160857     Medline TA:  Liver Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  779-86     Citation Subset:  IM    
Affiliation:
Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Area Under Curve
Biological Markers / blood*
Fatty Liver / blood*,  complications,  pathology
Female
Humans
Hyaluronic Acid / blood*
Liver Cirrhosis / blood*,  diagnosis,  etiology
Male
Middle Aged
Predictive Value of Tests
ROC Curve
Reproducibility of Results
Chemical
Reg. No./Substance:
0/Biological Markers; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic h...
Next Document:  Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in ...